Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued a Supplement to its Previously Issued “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

·19 min read
Sorrento Therapeutics, Inc.
Sorrento Therapeutics, Inc.

PALO ALTO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX) announced that its majority stockholder, Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today posted a supplement to its previously issued “Frequently Asked Questions” document under the “Investors” section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company held by Sorrento.

The supplement to the FAQs provides notice regarding the Depository Trust and Clearing Corporation’s removal of the contra-CUSIP on Scilex common stock that was distributed as a dividend to Sorrento’s stockholders and provides notice to brokerage firms, banks, dealers and similar organizations listed therein that a dividend confirmation had previously been distributed to such firms by Scilex’s transfer agent and requests that such firms contact Scilex’s transfer agent if they have not received such confirmation. The supplement also reiterates a question related to issues that may arise with respect to the dividend in connection with short positions in Sorrento common stock.

The supplement to the FAQs and related annex are included in this press release and can also be found Scilex’s website https://www.scilexholding.com/investors/faqs/

SUPPLEMENT TO
FREQUENTLY ASKED QUESTIONS
REGARDING THE DIVIDEND OF SCILEX HOLDING COMPANY COMMON STOCK BY SORRENTO THERAPEUTICS, INC.

This supplement is a supplement to the Frequently Asked Questions Regarding the Dividend of Scilex Holding Company Common Stock by Sorrento Therapeutics, Inc. (Sorrento) that was issued by Sorrento on January 29, 2023 (the FAQ), a copy of which can be found under the “Investors” section of its website at www.sorrentotherapeutics.com.

This supplement is being issued to update and supplement the information in the FAQ to notify investors regarding certain matters relating to the dividend and reiterate certain questions and answers from the FAQ. Capitalized terms used in this supplement shall have their respective meetings set forth in the FAQ.

NOTICE OF REMOVAL OF CONTRA-CUSIP BY DTCC

Effective as of February 2, 2023, the Depository Trust and Clearing Corporation has removed the “contra-CUSIP” that it had previously imposed on the Dividend Stock. Any shares of Dividend Stock held by your brokerage firm, bank, dealer or other similar organization for your benefit now bear only Scilex’s CUSIP number, which is 80880W106. If you are entitled to receive Dividend Stock, please contact your brokerage firm, bank, or other similar organization immediately to confirm that the CUSIP number appears on your brokerage statement with respect to your Dividend Stock.

NOTICE TO BROKERAGE FIRMS, BANKS, DEALERS AND OTHER SIMILAR ORGANIZATIONS

If the name of your firm, bank or other similar organization is set forth on Annex B of the FAQ, which Annex B is repeated below for convenience, and your firm, bank or similar organization has not received the Dividend Confirmation that was mailed to your firm, bank or similar organization, please contact Scilex’s transfer agent immediately to obtain a copy of the Dividend Confirmation. Scilex’s transfer agent’s contact information is as follows:

Continental Stock Transfer & Trust Company

Telephone Number: 800-509-5586

Email Address: cstmail@continentalstock.com

Several major brokers have confirmed to Sorrento and Scilex that they are adding the Scilex share positions to the individual brokerage accounts of Sorrento shareholders receiving the Dividend Stock

SUPPLEMENTAL QUESTION AND ANSWER

Q: If I loaned my shares of Sorrento common stock to short sellers or any other party as of the Record Date, am I still entitled to receive Dividend Stock as of the Payment Date? 

A: Only Record Holders as of the Record Date are entitled to receive the Dividend Stock. If you were the Record Holder as of the Record Date and are entitled to receive the Dividend Stock, but have not received the Dividend Stock, you may be entitled to receive Dividend Stock from the short seller or other party who borrowed your shares of Sorrento common stock, whether through the lending programs implemented by your brokerage firm, bank, dealer and other similar organization or otherwise. If you were a Record Holder as of the Record Date and have not received your Dividend Stock, please consult with your financial advisor, broker or other agent immediately to determine how to receive your Dividend Stock.

Annex B

Broker List

Broker Name

Broker Address

 

Broker Name

Broker Address

ABN AMRO CLEARING CHICAGO LLC

175 WEST JACKSON BLVD.
CHICAGO
IL ILLINOIS
60604 US

 

Albert Fried & Company LLC

45 BROADWAY, 24TH FLOOR
24TH FLOOR
NEW YORK
NY NEW YORK
10006 US

AMALGAMATED BANK

275 7TH AVENUE
NEW YORK
NY NEW YORK
10003 US

 

AMERICAN ENTERPRISE INVESTMENT SERVICES INC.

682 AMERIPRISE FINANCIAL CENTER
MINNEAPOLIS
MN MINNESOTA
55474 US

APEX CLEARING CORPORATION

2 GATEWAY CENTER 283-299 MARKET ST
16TH FLOOR
NEWARK
NJ NEW JERSEY
07102-5005 US

 

BANK OF AMERICA, NA/GWIM TRUST OPERATIONS

901 MAIN STREET
12TH FLOOR
DALLAS
TX TEXAS
23113 US

BANK OF NEW YORK MELLON

111 SANDERS CREEK PARKWAY 2ND FLOOR
2ND FLOOR
EAST SYRACUSE
NY NEW YORK
13057 US.

 

BARCLAYS CAPITAL INC.

DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZ
JERSEY CITY
NJ NEW JERSEY
07310 US

BARCLAYS CAPITAL INC.

DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZ
JERSEY CITY
NJ NEW JERSEY
07310 US

 

BMO CAPITAL MARKETS CORP.

3 2ND STREET
12TH FLOOR
JERSEY CITY
NJ NEW JERSEY
07302 US

BMO HARRIS BANK NA/TRUST

11270 W PARK PL
MILWAUKEE
WI WISCONSIN
53224 US

 

BMO Nesbitt Burns Inc., Toronto

250 YONGE STREET, 7TH FLOOR
7TH FLOOR
TORONTO
ON ONTARIO
M5B 2M8 CA CANADA

BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME BROKERAGE CUSTODIAN

100 WEST 33RD STREET
3RD FLOOR
NEW YORK
NY NEW YORK
10001

 

BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME BROKERAGE CUSTODIAN

100 WEST 33RD STREET
3RD FLOOR
NEW YORK
NY NEW YORK
10001

BNY MELLON

PO BOX 392002
500 ROSS STREET
PITTSBURGH
PA PENNSYLVANIA
15262 US

 

BNY MELLON/WEALTH MANAGEMENT

1 FREEDOM VALLEY DRIVE
OAKS
PA PENNSYLVANIA
19456 US

BNYMELLON

111 SANDERS CREEK PARKWAY 2ND FLOOR
2ND FLOOR
EAST SYRACUSE
NY NEW YORK
13057 US

 

BNYMELLON/RE BARCLAYS CAPITAL SECURITIES LTD.

ONE WALL STREET
NEW YORK
NY NEW YORK
10286

BNYMELLON/RE CACEIS BANK LUXEMBOURG

500 Grant St.
BNY Mellon Center
PITTSBURGH
PA PENNSYLVANIA
15258

 

BNYMELLON/RE CACEIS BANK, NETHERLANDS

111 SANDERS CREEK PARKWAY
EAST SYRACUSE
NY NEW YORK
13057

BNYMELLON/RE CHARLES STANLEY AND COMPANY, LIMITED

111 SANDERS CREEK PARKWAY 2ND FLOOR
2ND FLOOR
EAST SYRACUSE
NY NEW YORK
13057 US

 

BNYMELLON/RE ETF - ISHARES DTC/NSCC

111 SANDERS CREEK PARKWAY
EAST SYRACUSE
NY NEW YORK
13057

BNYMELLON/RE WINTERFLOOD SECURITIES LTD

500 Grant St.
BNY Mellon Center
PITTSBURGH
PA PENNSYLVANIA
15258

 

BOFA

4804 Deer Lake Drive East
FL9-803-04-04- 4th floor
JACKSONVILLE
FL FLORIDA
32246 US

BOFA

4804 Deer Lake Drive East
FL9-803-04-04- 4th floor
JACKSONVILLE
FL FLORIDA
32246 US

 

BOFA SECURITIES INC

4804 Deer Lake Drive East
FL9-803-04-04- 4th floor
JACKSONVILLE
FL FLORIDA
32246 US

BROWN BROTHERS HARRIMAN & CO.

140 BROADWAY
ATTN: CORPORATE ACTIONS VAULT
NEW YORK
NY NEW YORK
10005 US

 

BROWN BROTHERS HARRIMAN & CO./ETF

140 BROADWAY
NEW YORK
NY NEW YORK
10005

CALDWELL SECURITIES LTD./CDS**

55 UNIVERSITY AVENUE
SUITE 340
TORONTO
ON ONTARIO
M5J 2H7 CANADA

 

CANACCORD GENUITY CORP.

609 GRANVILLE ST
VANCOUVER
BC BRITISH COLUMBIA
V7Y 1H2 CA CANADA

CANTOR, FITZGERALD & CO.

135 E 57TH ST 5TH FL
NEW YORK
NY NEW YORK
10041 US

 

CDS CLEARING AND DEPOSITORY SERVICES INC.

100 ADELAIDE STREET WEST
TORONTO
ON ONTARIO
M5H 1S3 CA CANADA

CETERA INVESTMENT SERVICES LLC

400 FIRST STREET SOUTH, SUITE 300
SUITE 300
ST. CLOUD
MN MINNESOTA
56302-0283 US

 

CHARLES SCHWAB & CO., INC.

211 MAIN STREET
SAN FRANCISCO
CA CALIFORNIA
94105 US

CI INVESTMENT SERVICES INC.

199 BAY STREET
SUITE 2600
TORONTO
ON ONTARIO
M5L 1E2 CA CANADA

 

CIBC WORLD MARKETS INC./CDS**

161 BAY STREET 10 FL
TORONTO
ON ONTARIO
M5J 2S8 CA CANADA

CITIBANK, N.A./ETF

3800 CITIGROUP CENTER
B2/2
TAMPA
FL FLORIDA
33610

 

CITIBANK, NATIONAL ASSOCIATION

3800 CITIBANK CENTER TAMPA
BLDG.B FIRST FLOOR ZONE 8
TAMPA
FL FLORIDA
33610-9122 US

CITIGROUP GLOBAL MARKETS, INC.

580 CROSSPOINT PARKWAY
GETZVILLE
NY NEW YORK
14068 US

 

CLEAR STREET LLC

4 World Trade Center, 45th Floor
150 Greenwich Street
NEW YORK
NY NEW YORK
10007

CLEARSTREET IO

55 BROADWAY (SUITE 2102)
CORPORATE ACTIONS
NEW YORK
NEW YORK
10006 US

 

COMMERCE BANK

922 WALNUT STREET
MAIL STOP TBTS-2
KANSAS CITY
MO MISSOURI
64106 US

COR CLEARING LLC

9300 UNDERWOOD AVE
SUITE 400
OMAHA
NE NEBRASKA
68114 US

 

Credential Securities Inc.

800-1111 WEST GEORGIA STREET
VANCOUVER
BC BRITISH COLUMBIA
V6E 4T6 CA CANADA

CREST INTERNATIONAL NOMINEES LIMITED

33 CANNON STREET
LONDON
EC4M 5SB GB UNITED KINGDO

 

CURVATURE SECURITIES, LLC

39 MAIN STREET
CHATHAM
NJ NEW JERSEY
07928 US

D.A. DAVIDSON & CO.

8 3RD STREET NORTH
GREAT FALLS
MT MONTANA
59401 US

 

DEPOSITO CENTRAL DE VALORES S.A., DEPOSITO DE VALORES

AVENIDA APOQUINDO # 4001
FLOOR 12, C.P.
7550162, SANTIAGO
CL CHILE

DESJARDINS SECURITIES INC.

1253 McGill College
10TH FLOOR
MONTREAL
QUEBEC
H3B 2Y5 CA CANADA

 

DEUTSCHE BANK AG NY/US CUSTODY

1251 Avenue Of The Americas
NEW YORK
NY NEW YORK
10020

DEUTSCHE BANK SECURITIES INC.

60 WALL STREET
9TH FLOOR
NEW YORK
NY NEW YORK
10005 US

 

DRIVEWEALTH, LLC

15 EXCHANGE PLACE
10TH FLOOR
JERSEY CITY
NEW JERSEY
07302

E*TRADE CLEARING LLC

HARBORSIDE FINANCIAL CENTER
501 PLAZA 11
JERSEY CITY
NJ NEW JERSEY
07311 US

 

EDWARD D. JONES & CO., L.P.

12555 MANCHESTER ROAD
ST. LOUIS
MO MISSOURI
63131-3729 US

EDWARD D. JONES & CO., L.P.

201 PROGRESS PARKWAY
MARYLAND HEIGHTS
MO MISSOURI
63043 US

 

FIDELITY CLEARING CANADA ULC/CDS**

483 BAY ST.
SOUTH TOWER
TORONTO
ON ONTARIO
M5G2N7 CA CANADA

FIFTH THIRD BANK

5001 KINGSLEY DRIVE
MAIL DROP 1MOB28
CINCINNATI
OH OHIO
45227 US

 

FOLIO INVESTMENTS, INC.

8180 GREENSBORO DRIVE
8TH FLOOR
MCLEAN
VA VIRGINIA
22102 US

FUTU CLEARING INC.

12750 Merit Drive
SUITE 475
DALLAS
TX TEXAS
75251

 

GMP SECURITIES L.P.

145 KING STREET WEST, SUITE 300
11TH FLOOR
TORONTO
ON ONTARIO
MJ5 1J8 CA CANADA

GOLDMAN, SACHS & CO. LLC

222 SOUTH MAIN STREET
Attn: Mandatory Corporate Actions
SALT LAKE CITY
UT UTAH
84101 US

 

HAYWOOD SECURITIES INC./CDS**

200 BURRARD ST
WATERFRONT CENTRE SUITE 700
VANCOUVER
BC BRITISH COLUMBIA
V6C 3L6 CANADA

HILLTOP SECURITIES INC.

1201 ELM ST.
35TH FLOOR
DALLAS
TX TEXAS
75270 US

 

HRT FINANCIAL LLC

150 GREENWICH STREET (ATTN: SETTLEMENT) FOUR WORLD TRADE CENTER
57TH FLOOR
NEW YORK
NY NEW YORK
10007 US

HSBC BANK USA, NA/HSBC CUSTODY & CLEARING SERVICES FOR STOCK LOAN

452 FIFTH AVENUE
ATTN: HBUS CCS SETTS
NEW YORK
NY NEW YORK
10018 US

 

HSBC BANK USA, NATIONAL ASSOCIATION

452 FIFTH AVENUE
ATTN: HBUS CCS SETTS
NEW YORK
NEW YORK
10018 US

INTERACTIVE BROKERS LLC

2 PICKWICK PLAZA
2ND FLOOR
GREENWICH
CT CONNECTICUT
06830 US

 

J.P. MORGAN CHASE BANK NA/FBO BLACKROCK CTF

1111 POLARIS PARKWAY
COLUMBUS
OH OHIO
43240

J.P. MORGAN CLEARING CORP.

FOUR CHASE METROTECH CENTER
3RD FLOOR
BROOKLYN
NY NEW YORK
11201 US

 

JANNEY MONTGOMERY SCOTT LLC

1717 ARCH STREET
17TH FLOOR
PHILADELPHIA
PA PENNSYLVANIA
19103 US

JEFFERIES LLC

101 HUDSON STREET, 11th Floor
NEW JERSEY
NJ NEW JERSEY
07302 US

 

JPMORGAN CHASE BANK, NATIONAL ASSOCIATION

FOUR CHASE METROTECH CENTER
3RD FLOOR
BROOKLYN
NY NEW YORK
11201 US

JPMORGAN CHASE BANK/EUROCLEAR BANK

FOUR CHASE METROTECH CENTER
3RD FLOOR
BROOKLYN
NY NEW YORK
11245 US

 

JPMORGAN CHASE BANK/IA

FOUR CHASE METROTECH CENTER
3RD FLOOR
BROOKLYN
NY NEW YORK
11201 US

KEYBANK NATIONAL ASSOCIATION

4900 TIEDEMAN RD
BROOKLYN
OH OHIO
44144 US

 

LAURENTIAN BANK SECURITIES INC.

1981 MCGILL COLLEGE AVE.
SUITE 100
MONTREAL
QUEBEC
H3A 3K3 CA CANADA

LPL FINANCIAL LLC

4707 EXECUTIVE DRIVE
SAN DIEGO
CA CALIFORNIA
92121 US

 

MANUFACTURERS AND TRADERS TRUST COMPANY

ONE M&T PLAZA
TRUST OPS 8TH FLOOR
BUFFALO
NY NEW YORK
14203 US

MANULIFE SECURITIES INCORPORATED

1235 NORTH SERVICE ROAD WEST
OAKVILLE
ON ONTARIO
L6M 2W2 CA CANADA

 

MARSCO INVESTMENT CORPORATION

101 EISENHOWER PARKWAY
ROSELAND
NJ NEW JERSEY
07068 US

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED

4804 Deer Lake Drive East
FL9-803-04-04- 4th floor
JACKSONVILLE
FL FLORIDA
32246 US

 

MIRAE ASSET SECURITIES (USA) INC./STOCK LOAN CONDUIT ACCOUNT

810 SEVENTH AVE
37TH FLOOR
NEW YORK
NY NEW YORK
10019

MIRAE ASSET SECURITIES (USA), INC.

810 SEVENTH AVE
37TH FLOOR
NEW YORK
NY NEW YORK
10019

 

MITSUBISHI UFJ TRUST & BANKING CORPORATION, NEW YORK BRANCH

280 PARK AVE
39TH FL-WEST BLDG
NEW YORK
NY NEW YORK
10017

Morgan Stanley

1300 THAMES STREET
THAMES STREET WHARF
BALTIMORE
MD MARYLAND
21231 US

 

MORGAN STANLEY & CO. LLC

1300 THAMES ST.
BALTIMORE
MD MARYLAND

MORGAN STANLEY SMITH BARNEY LLC

1 NEW YORK PLAZA
39TH FLOOR
NEW YORK
NY NEW YORK
10004 US

 

MURIEL SIEBERT & CO., INC.

77 SUMMER STREET
3RD FLOOR
BOSTON
MA MASSACHUSETTS
02210 US

NATIONAL FINANCIAL SERVICES LLC

499 WASHINGTON BOULEVARD
5TH FLOOR
JERSEY CITY
NJ NEW JERSEY
07310 US

 

NBCN INC.

1010 rue De La Gauchetière
Mezzanine 100
MONTREAL
QUEBEC
H3B 5J2 CA CANADA

NOMURA INTERNATIONAL TRUST COMPANY

309 WEST 49TH STREET
10TH FLOOR
NEW YORK
NY NEW YORK
10019 US

 

ODLUM BROWN LIMITED

250 HOWE STREET
SUITE 1100
VANCOUVER
BC BRITISH COLUMBIA
V6C 3R8 CA CANADA

OPPENHEIMER & CO. INC.

85 BROAD STREET
NEW YORK
NY NEW YORK
10004 US

 

PERSHING LLC

1 PERSHING PLAZA
JERSEY CITY
NJ NEW JERSEY
07399 US

PHILLIP CAPITAL INC.

141 W. JACKSON BLVD. SUITE 3050
CHICAGO
IL ILLINOIS
60604 US

 

PI FINANCIAL CORP.

666 BURRARD ST
SUITE 1900
VANCOUVER
BC BRITISH COLUMBIA
V6C 3N1 CA CANADA

PNC BANK, NATIONAL ASSOCIATION

4100 W 150TH STREET
ASSET MOVEMENT TEAM 3RD FL, LOCATOR B7-YB17-03-03
CLEVELAND
OH OHIO
44135 US

 

PRINCIPAL BANK

711 HIGH STREET
DES MOINES
IA IOWA
50392

QUESTRADE INC./CDS**

5650 YONGE ST.,
Suite 1700
TORONTO
ON ONTARIO
M2M 4G3 CA CANADA

 

Raymond James & Associates, Inc.

880 CARILLON PKWY
ST. PETERSBURG
FL FLORIDA
33733-2749 US

RAYMOND JAMES LTD.

925 WEST GEORGIA STREET
SUITE 2200
VANCOUVER
BC BRITISH COLUMBIA
V6C 3L2 CA CANADA

 

RBC CAPITAL MARKETS, LLC

60 SOUTH 6TH ST.
MINNEAPOLIS
MN MINNESOTA
55402 US

RBC DOMINION SECURITIES INC

21 COMMERCE COURT SOUTH
2ND FLOOR
TORONTO
ON ONTARIO
M5L 1A7 CANADA

 

RELIANCE TRUST COMPANY

1100 ABERNATHY RD.
500 NORTHPARK SUITE 400
ATLANTA
GA GEORGIA
30113 US

RELIANCE TRUST COMPANY

4900 W. BROWN DEER RD
MILWAUKEE
WI WISCONSIN
53223 US

 

ROBERT W. BAIRD & CO. INCORPORATED

777 E WISCONSIN AVE
9TH FLOOR
MILWAUKEE
WI WISCONSIN
53202 US

ROBINHOOD SECURITIES, LLC

500 COLONIAL CENTER PARKWAY
SUITE 100
LAKE MARY
FL FLORIDA
32746 US

 

SAFRA SECURITIES LLC

546 5TH AVENUE
NEW YORK
NY NEW YORK
10036 US

SCOTIA CAPITAL (USA) INC.

150 KING STREET W
5TH FLOOR
TORONTO
ON ONTARIO
M5H 1J9 CA CANADA

 

SEI PRIVATE TRUST COMPANY

1 FREEDOM VALLEY DRIVE
OAKS
PA PENNSYLVANIA
19456 US

SEI PRIVATE TRUST COMPANY

1 FREEDOM VALLEY DRIVE
OAKS
PA PENNSYLVANIA
19456 US

 

SG AMERICAS SECURITIES, LLC

480 WASHINGTON BLVD.
20TH FLOOR
JERSEY CITY
NJ NEW JERSEY
07310 US

SSB - BLACKROCK INSTITUTIONAL TRUST

50 California Street
San Francisco
CA CALIFORNIA
94163

 

SSB - TRUST CUSTODY

30 ADELAIDE ST EAST
SUITE 800
TORONTO
ON ONTARIO
M5C 3G6 CA CANADA

SSB&T CO/CLIENT CUSTODY SERVICES

1776 HERITAGE DRIVE
NORTH QUINCY
MA MASSACHUSETTS
02171

 

STATE STREET BANK & TRUST CO

16 WALL STREET
5TH FLOOR
NEW YORK
NY NEW YORK
10005 US

STATE STREET BANK & TRUST COMPANY / ISHARES EUROPE

1776 HERITAGE DRIVE
NORTH QUINCY
MA MASSACHUSETTS
02171

 

STATE STREET BANK & TRUST/STATE STREET TOTALETF

1776 Heritage Drive
NORTH QUINCY
MA MASSACHUSETTS
02717

STATE STREET BANK AND TRUST COMPANY

30 ADELAIDE ST EAST
SUITE 800
TORONTO
ON ONTARIO
M5C 3G6 CA CANADA

 

STIFEL, NICOLAUS & COMPANY, INCORPORATED

501 N BROADWAY
ST. LOUIS
MO MISSOURI
63102 US

STONEX FINANCIAL INC.

2 PERIMETER PARK SOUTH
SUITE 100 W
BIRMINGHAM
AL ALABAMA
35243 US

 

TD AMERITRADE CLEARING, INC.

200 S 108TH AVE
OMAHA
NE NEBRASKA
68154 US

TD WATERHOUSE CANADA INC
ATTN: MANDATORY CORPORATE ACTIONS

77 BLOOR STREET WEST
3RD FLOOR
TORONTO
ON ONTARIO
M5S 1M2 CA CANADA

 

TEXAS TREASURY SAFEKEEPING TRUST COMPANY

208 E 10TH ST
AUSTIN
TX TEXAS
78701 US

THE BANK OF NEW YORK MELLON

500 GRANT STREET
27TH FLOOR
PITTSBURGH
PA PENNSYLVANIA
15258 US

 

THE HUNTINGTON NATIONAL BANK

7 EASTON OVAL EA4E62
COLUMBUS
OH OHIO
43209 US

THE NORTHERN TRUST COMPANY

333 South Wabash Ave, 32nd Floor
Attn: Trade Securities Processing
CHICAGO
IL ILLINOIS
60603 US

 

TRADESTATION SECURITIES, INC.

120 RIVERSIDE PLAZA
SUITE 1650
CHICAGO
IL ILLINOIS
60606 US

U.S. BANCORP INVESTMENTS, INC.

60 LIVINGSTON AVE
EP-MN-WN1B
ST. PAUL
MN MINNESOTA
55107-1419 US

 

U.S. BANK N.A./ETF

1555 N RIVER CENTER DRIVE
MILWAUKEE
WI WISCONSIN
53212

U.S. BANK NATIONAL ASSOCIATION

1555 NORTH RIVERCENTER DRIVE, SUITE 302
SUITE 302
MILWAUKEE
WI WISCONSIN
53212 US

 

UBS AG

480 WASHINGTON BLVD.
12TH FLOOR
JERSEY CITY
NJ NEW JERSEY
07310 US

UBS FINANCIAL SERVICES INC.

1000 HARBOR BOULEVARD
WEEHAWKEN
NJ NEW JERSEY
07086 US

 

UBS SECURITIES LLC

677 WASHINGTON BLVD
STAMFORD
CT CONNECTICUT
06901 US

UMB BANK, NATIONAL ASSOCIATION

928 GRAND BLVD
KANSAS CITY
MO MISSOURI
64106 US

 

VANGUARD MARKETING CORPORATION

100 VANGUARD BLVD
MALVERN
PA PENNSYLVANIA
19355 US

VELOCITY CLEARING, LLC

1301 Route 36
Suite 109 (Attn: Chris Felicetti)
HAZLET
NEW JERSEY
7730 US

 

VELOX CLEARING LLC

2400 E. KATELLA AVENUE
SUITE 725A
ANAHEIM
CA CALIFORNIA
92806 US

VIRTU AMERICAS LLC

ONE LIBERTY PLAZA, 165 BROADWAY
5TH FLOOR
NEW YORK
NY NEW YORK
10006 US

 

VISION FINANCIAL MARKETS LLC

4 HIGH RIDGE PARK
SUITE 100
STAMFORD
CT CONNECTICUT
06905 US

WEDBUSH SECURITIES INC

1000 WILSHIRE BLVD
8TH FLOOR
LOS ANGELES
CA CALIFORNIA
90017 US

 

WEDBUSH SECURITIES INC.

1000 WILSHIRE BLVD.
LOS ANGELES
CA CALIFORNIA
90017 US

WELLS FARGO BANK, N.A./SIG

733 MARQUETTE AVE 4TH FLOOR
MAC N9306-04D
MINNEAPOLIS
MN MINNESOTA
55402 US

 

WELLS FARGO CLEARING SERVICES LLC

1 NORTH JEFFERSON
MAIL CODE: H0006-094
ST. LOUIS
MO MISSOURI
63103 US

WELLS FARGO SECURITIES, LLC

1525 WEST W T HARRIS BLVD
CHARLOTTE
NC NORTH CAROLINA
28262 US

 

WILSON-DAVIS & CO., INC.

236 SOUTH MAIN STREET
SALT LAKE CITY
UT UTAH
84101 US

About Scilex Holding Company 

Scilex Holding Company, a majority-owned by Sorrento Therapeutics, Inc., is an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Scilex is uncompromising in its focus to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life. Results from the Phase III Pivotal Trial C.L.E.A.R Program for SEMDEXA™, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022.  Scilex has applied for breakthrough therapy designation and expects to seek priority review for SEMDEXA™ for the treatment of sciatica.  Scilex targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with moderate to severe pain.  Scilex launched its first commercial product in October 2018, in-licensed a commercial product in June 2022, and is developing its late-stage pipeline, which includes a pivotal Phase 3 candidate and one Phase 2 and one Phase 1 candidate.  Its commercial product, ZTlido® (lidocaine topical system) 1.8%, or ZTlido®, is a prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain.  Scilex in-licensed the exclusive right to commercialize Gloperba® (colchicine USP) oral solution, an FDA-approved prophylactic treatment for painful gout flares in adults, in the U.S. Scilex is planning to commercialize Gloperba® in 2023 and is well-positioned to market and distribute the product. Scilex’s three product candidates are SP-102 (injectable dexamethasone sodium phosphate viscous gel product containing 10 mg dexamethasone), or SEMDEXA™, a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, with FDA Fast Track status; SP-103 (lidocaine topical system) 5.4%, a Phase 2, triple-strength formulation of ZTlido®, for the treatment of low back pain, with FDA Fast Track status; and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule, for the treatment of chronic pain, fibromyalgia that has completed multiple Phase 1 trial programs and expected to initiate Phase 2 trials this year. For further information regarding the SP-102 Phase 3 efficacy trial, see NCT identifier NCT03372161 – Corticosteroid Lumbar Epidural Analgesia for Radiculopathy – Full Text View – ClinicalTrials.gov.

Scilex Holding Company is headquartered in Palo Alto, California, with operations in both Palo Alto and San Diego, California. For further information please visit www.scilexholding.com.

About Sorrento Therapeutics, Inc.

Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. Sorrento's multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as Abivertinib, next-generation tyrosine kinase inhibitors (“TKIs”), fully human antibodies (“G-MAB™ library”), immuno-cellular therapies (“DAR-T™”), antibody-drug conjugates (“ADCs”), and oncolytic virus (“Seprehvec™”). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including STI-1558, COVI-MSC™; and diagnostic test solutions, including COVIMARK™.

Sorrento's commitment to life-enhancing therapies for patients is also demonstrated by our effort to advance a TRPV1 agonist, non-opioid pain management small molecule, resiniferatoxin (“RTX”), and SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA™), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, and to commercialize ZTlido® (lidocaine topical system) 1.8% for the treatment of postherpetic neuralgia (PHN). RTX has been cleared for a Phase II trial for intractable pain associated with cancer and a Phase II trial in osteoarthritis patients. Positive final results from the Phase III Pivotal Trial C.L.E.A.R. Program for SEMDEXA™, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. ZTlido® was approved by the FDA on February 28, 2018.

For more information visit www.sorrentotherapeutics.com.

Contacts:

For Scilex Holding Company

Jaisim Shah
Chief Executive Officer
Scilex Holding Company
960 San Antonio Road
Palo Alto, CA 94303
Office: (650) 516-4310

Email: jshah@scilexpharma.com

Website:  www.sorrentotherapeutics.com and www.scilexholding.com

Investors and Media Contact:
Elizabeth Czerepak
Email: mediarelations@sorrentotherapeutics.com
Website: www.sorrentotherapeutics.com

Sorrento® and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc.

G-MAB™, DAR-T™, Seprehvec™, SOFUSA™, COVI-MSC™, COVIMARK™, Ovydso™ and Fujovee™ are trademarks of Sorrento Therapeutics, Inc.

SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company.  A proprietary name review by the FDA is planned.

ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company.

Gloperba® is an exclusive, transferable license to use the trademark by Scilex Holding Company.

All other trademarks are the property of their respective owners.

© 2023 Sorrento Therapeutics, Inc. All Rights Reserved.